Figure 3 | Scientific Reports

Figure 3

From: Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals

Figure 3The alternative text for this image may have been generated using AI.

AmB-NA releases monomeric AmB in sustained manner over extended time period: Various AmB-NA formulations were incubated in (A) sterile 20 mM phosphate buffer saline (pH 7.4) (B) Serum. (C) Histidine Buffer. The amount of AmB released at various time points was analysed spectrophotometrically at 405 nm. Each time point represents an average of three runs ± SD.

Back to article page